![Niels Reichardt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Niels Reichardt worked as a Scientific Director at Metabolic Renal Disease SL and as a Group Leader at CICbiomagune institute.
He also worked as a Research Scientist at GlycoForm Ltd.
for a brief period.
He obtained a doctorate degree from Universität Konstanz.
Precedenti posizioni note di Niels Reichardt
Società | Posizione | Fine |
---|---|---|
GlycoForm Ltd.
![]() GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | Direttore Tecnico/Scientifico/R&S | 01/01/2006 |
CICbiomagune institute | Corporate Officer/Principal | - |
Metabolic Renal Disease SL
![]() Metabolic Renal Disease SL Medical SpecialtiesHealth Technology Metabolic Renal Disease SL develops mass-spectrometry based tools for targeted metabolomics. It is a biotechnology company that specializes in the field of biometrics. The company's activity is centered in the development of analytical tools based in mass spectrometry and oriented to metabolomics for the identification, quantification and interpretation of metabolites in biofluids. The firm offers a range of applications, specially related to toxicology and pharmacological evaluation. Metabolic Renal Disease was founded in 2008 and is headquartered in San Sebastian, Spain. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Niels Reichardt
Universität Konstanz | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
GlycoForm Ltd.
![]() GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | Health Technology |
Metabolic Renal Disease SL
![]() Metabolic Renal Disease SL Medical SpecialtiesHealth Technology Metabolic Renal Disease SL develops mass-spectrometry based tools for targeted metabolomics. It is a biotechnology company that specializes in the field of biometrics. The company's activity is centered in the development of analytical tools based in mass spectrometry and oriented to metabolomics for the identification, quantification and interpretation of metabolites in biofluids. The firm offers a range of applications, specially related to toxicology and pharmacological evaluation. Metabolic Renal Disease was founded in 2008 and is headquartered in San Sebastian, Spain. | Health Technology |
CICbiomagune institute |
- Borsa valori
- Insiders
- Niels Reichardt